CodeMap® 
150 North Wacker Drive
Suite 1870
Chicago, IL 60606
847-381-5465 Phone
847-381-4606 Fax
customerservice@codemap.com
      


User Information

Create New Account

Lost Password

Username:
Password:


Quick Links

LCDs and LCAs
by Contractor

PLA Codes

Laboratory Fee Schedule

2022
2021

Physician Fee Schedule

2022
2021

OPPS Fee Schedule

2022-October
2022-July

ASC Fee Schedule

2022-October
2022-July

APC Codes

2022-October
2022-July

DRG Codes

2022
2021

ASP Drug Pricing Files

October 2022
July 2022


CMS Transmittals



CodeMap® LCD-L35025

 

Printer Friendly Version

L35025
LCD for MolDX: Molecular Diagnostic Tests (MDT) (L35025)
See related Articles:
A53098-Billing and Coding: MolDX: Afirma™ Assay by Veracyte Update
A53100-Billing and Coding: Lab: Avise PG Assay
A53101-Billing and Coding: MolDX: bioTheranostics Cancer TYPE ID® Update
A53103-Billing and Coding: MolDX: HERmark® Assay by Monogram Update
A53104-Billing and Coding: MolDX: MammaPrint
A53105-Billing and Coding: MolDX: Oncotype DX® Breast Cancer Assay
A53106-MolDX: Oncotype DX® Colon Cancer Assay Update
A53107-Billing and Coding: MolDX: Progensa® PCA3 Assay Coverage Update
A53108-Billing and Coding: MolDx: ResponseDX Tissue of Origin®
A53110-Billing and Coding: Lab: Vectra™ DA
A54018-Billing and Coding: MolDX: FDA-Approved BRAF Tests
A54021-Billing and Coding: MolDX: FDA-Approved EGFR Tests
A54338-Billing and Coding: MolDX: Germline testing for use of PARP inhibitors
A54472-Billing and Coding: MolDX: FDA-Approved KRAS Tests
A55695-Billing and Coding: MolDX: Abbott RealTime IDH1 and IDH2 testing for Acute Myeloid Leukemia (AML)
A55822-Billing and Coding: MolDX: ThermoFisher Oncomine Dx Target Test For Non-Small Cell Lung Cancer
A56853-Billing and Coding: MolDX: Molecular Diagnostic Tests (MDT)

Contractor Information

Contractor Name: Palmetto GBA - Full list of policies of this Medicare Contractor

Contractor Number: 11201

Contractor Type: MAC A

LCD Information

LCD ID Number: L35025 Status: A-Approved

LCD Title: MolDX: Molecular Diagnostic Tests (MDT)

Geographic Jurisdiction: South Carolina Other Jurisdictions

Original Determination Effective Date: 10/01/2015

Original Determination Ending Date:

Revision Effective Date: 12/12/2019

Revision End Date:

CMS National Coverage Policy:

Title XVIII of the Social Security Act (SSA) §1862(a)(1)(A), states that no Medicare payment shall be made for items or services that "are not reasonable and necessary for the diagnosis or treatment of illness or injury or to improve the functioning of malformed body member."

Title XVIII of the Social Security Act (SSA) §1862(a)(1)(D), Investigational or Experimental.

45 Code of Federal Regulations (CFR) §162.1002 (a)(5), Medical data code sets

Pub 100-08 PIM, Ch. 13, Sec 13.1.3, Program Integrity Manual, “LCDs consist of only “reasonable and necessary” information.


Sorry, you need to login or register to view additional sections of this Medicare policy.

--
*
All information on this web site is compiled directly from information obtained from the Center for Medicare and Medicaid Services (CMS) and from its Contractors.

CodeMap® has made every reasonable effort to ensure the accuracy of the information contained on this web site. However, the ultimate responsibility for correct coding and claims submission lies with the provider of services. CodeMap® makes no representation, warranty, or guarantee that this compilation of Medicare information is error-free or that the use of this information will result in Medicare coverage and subsequent payment of claims. Final coverage and payment of claims are subject to many factors exclusively controlled by CMS and its contractors.

No part of this web page or data displayed may be redistibuted or used without the express written consent of Wheaton Partners, LLC.

12/08/2022 12:25:47 3.225.221.130


CodeMap® is a Registered Trademark of Wheaton Partners, LLC.